机译:功能但不是黑色素瘤肽特异性CD8 + T细胞的表型与多孔蛋白肽疫苗试验中的存活相关(ECOG 1696)
Department of Pathology University of Pittsburgh Cancer Institute University of Pittsburgh School;
Department of Pathology University of Pittsburgh Cancer Institute University of Pittsburgh School;
Department of Biostatistics and Computational Biology Dana Farber Cancer Institute Boston MA;
Department of Pathology University of Pittsburgh Cancer Institute University of Pittsburgh School;
Department of Pathology University of Pittsburgh Cancer Institute University of Pittsburgh School;
Department of Pathology University of Pittsburgh Cancer Institute University of Pittsburgh School;
Department of Pathology University of Pittsburgh Cancer Institute University of Pittsburgh School;
Department of Pathology University of Pittsburgh Cancer Institute University of Pittsburgh School;
CD8 + T cells; immune monitoring; melanoma; peptide-based vaccine; tetramer;
机译:功能但不是黑色素瘤肽特异性CD8 + T细胞的表型与多孔蛋白肽疫苗试验中的存活相关(ECOG 1696)
机译:黑色素瘤多肽多表位疫苗接种治疗转移性黑色素瘤患者的细胞毒性T细胞和辅助T细胞的随机II期临床试验(E1602)
机译:用修饰的gp100肽对HLA-A2阳性黑色素瘤患者进行辅助免疫可诱导肽特异性CD8 + T细胞应答。
机译:患者临床试验与患有转移和/或复发性固体瘤的患者的HER-2 B细胞嵌合和多型肽疫苗
机译:早期定位的SIV特异性CD8 T细胞对致病性SIV的反应与成功的SIV疫苗相关。
机译:功能但不是黑色素瘤肽特异性CD8 + T细胞的表型与多孔肽肽疫苗试验中的存活相关(ECOG 1696)
机译:多孔磷染色蛋白肽的随机期II试验,用于细胞毒性T细胞和转移黑素瘤患者的细胞毒性T细胞和辅助T细胞(E1602)